Future Health ESG Debt to Equity Ratio 2022-2023 | FHLT

Current and historical debt to equity ratio values for Future Health ESG (FHLT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Future Health ESG debt/equity for the three months ending December 31, 2023 was 0.00.
Future Health ESG Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2023-12-31 $0.03B $-0.01B -2.68
2023-09-30 $0.03B $-0.01B -2.73
2023-06-30 $0.03B $-0.01B -2.74
2023-03-31 $0.03B $-0.01B -2.79
2022-12-31 $0.03B $-0.01B -2.84
2022-09-30 $0.21B $-0.01B -24.50
2022-06-30 $0.21B $-0.01B -25.29
2022-03-31 $0.21B $-0.01B -27.48
2021-12-31 $0.00B 0.00
2021-09-30 $0.21B $-0.01B -28.61
2021-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.000B $0.000B
Future Health ESG Corp. entered into a definitive business combination agreement with Excelera DCE.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.242B 54.20
Hims & Hers Health (HIMS) United States $14.325B 148.84
Tempus AI (TEM) United States $11.867B 0.00
Inspire Medical Systems (INSP) United States $4.712B 73.62
IRhythm Technologies (IRTC) United States $4.463B 0.00
Privia Health (PRVA) United States $2.963B 202.50
Enovis (ENOV) United States $2.134B 11.90
Clover Health Investments (CLOV) United States $1.737B 0.00
Schrodinger (SDGR) United States $1.735B 0.00
Phreesia (PHR) United States $1.534B 0.00
Omnicell (OMCL) United States $1.312B 23.14
Azenta (AZTA) United States $1.277B 59.36
10x Genomics (TXG) United States $1.180B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.589B 0.00
Talkspace (TALK) United States $0.514B 153.50
Veradigm (MDRX) United States $0.455B 0.00
Standard BioTools (LAB) United States $0.433B 0.00
Claritev (CTEV) United States $0.405B 0.00
TruBridge (TBRG) United States $0.375B 831.67
Health Catalyst (HCAT) United States $0.299B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.208B 0.00
Nyxoah SA (NYXH) Belgium $0.197B 0.00
EUDA Health Holdings (EUDA) Singapore $0.156B 0.00
Pulmonx (LUNG) United States $0.133B 0.00
American Well (AMWL) United States $0.119B 0.00
MDxHealth SA (MDXH) Belgium $0.084B 0.00
CareCloud (CCLD) United States $0.084B 3.19
Retrieve Medical Holdings (RMHI) United States $0.083B 0.00
111 (YI) China $0.068B 0.00
Outset Medical (OM) United States $0.062B 0.00
P3 Health Partners (PIII) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) Netherlands $0.043B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Movano (MOVE) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00